CELG


Notice: Use of undefined constant MSSQL_BOTH - assumed 'MSSQL_BOTH' in /var/www/api.comtex.com/htdocs/api_db.php on line 43

Notice: Use of undefined constant MSSQL_ASSOC - assumed 'MSSQL_ASSOC' in /var/www/api.comtex.com/htdocs/api_db.php on line 43

Notice: Use of undefined constant MSSQL_NUM - assumed 'MSSQL_NUM' in /var/www/api.comtex.com/htdocs/api_db.php on line 43

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 41

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 42

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 43

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 46

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 47

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 48

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 49

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 50

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 52

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 54

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 55

Warning: number_format() expects parameter 1 to be double, string given in /var/www/api.comtex.com/htdocs/api_functions/marketdata/market_data_widget.api.php on line 56

Detailed Quote (CELG)

Last Trade Volume
Change
Change % NA Market Cap.0K
Today's High 52 Week High
Today's Low 52 Week Low
Bid EPS NA
Ask P/E Ratio NA
Open Div. Per Share
Previous Close ExchangeNA

Related News

January 25, 2020

Below are the three companies in the Biotechnology industry with the highest cash equivalents (CE). Analysts use CE as a measure to compare the cash cushion of companies in the same industry.

Amgen Inc ranks highest with a CE of $42,000....

January 11, 2020

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks...

January 7, 2020

SmarTrend identified an Uptrend for Celgene Corp (NASDAQ:CELG) on August 26th, 2019 at $97.27. In approximately 4 months, Celgene Corp has returned 11.28% as of today's recent price of $108.24.

Celgene Corp...

January 4, 2020

Below are the three companies in the Biotechnology industry with the highest debt to EBITDA ratios. This ratio indicates how many years of EBITDA would be necessary in order to pay back all the debt (assuming Debt and EBITDA are constant)....

December 28, 2019

SmarTrend identified an Uptrend for Celgene Corp (NASDAQ:CELG) on August 26th, 2019 at $97.27. In approximately 4 months, Celgene Corp has returned 11.28% as of today's recent price of $108.24.

Over the...

December 22, 2019

Below are the three companies in the Biotechnology industry with the highest cash equivalents (CE). Analysts use CE as a measure to compare the cash cushion of companies in the same industry.

Amgen Inc ranks highest with a CE of $42,000....

December 21, 2019

Below are the three companies in the Biotechnology industry with the highest cash equivalents (CE). Analysts use CE as a measure to compare the cash cushion of companies in the same industry.

Amgen Inc ranks highest with a CE of $42,000....

December 8, 2019

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks...

December 5, 2019

Below are the three companies in the Biotechnology industry with the highest debt to EBITDA ratios. This ratio indicates how many years of EBITDA would be necessary in order to pay back all the debt (assuming Debt and EBITDA are constant)....

December 4, 2019

SmarTrend identified an Uptrend for Celgene Corp (NASDAQ:CELG) on August 26th, 2019 at $97.27. In approximately 3 months, Celgene Corp has returned 11.28% as of today's recent price of $108.24.

In the past...